Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein L pseudogene 2 (HNRNPLP2)

Target
HNRNPLP2
01

Overview

HNRNPLP2, or heterogeneous nuclear ribonucleoprotein L pseudogene 2, is annotated as a pseudogene on chromosome 15 (location 15q15) and does not encode a functional protein[5]. Pseudogenes are regions of DNA that resemble known genes but are typically non-functional due to mutations or lack of necessary regulatory elements. There is no evidence in the biomedical literature or genetic databases that HNRNPLP2 is expressed as a protein, functions as a therapeutic target, is involved in disease, or interacts with known drugs. It should not be confused with the functional gene heterogeneous nuclear ribonucleoprotein L (HNRNPL), which is an RNA-binding protein involved in mRNA processing and has recognized roles in health and disease[1][6]. The designation as a pseudogene means that this entry is not a valid therapeutic target in drug discovery or molecular medicine. In summary, HNRNPLP2 is a pseudogene with no known biological or pharmacological function and is not considered a drug target or disease-associated receptor/protein[5].

Other names
heterogeneous nuclear ribonucleoprotein L pseudogene 2

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein L pseudogene 2 (HNRNPLP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein L pseudogene 2 (HNRNPLP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call